Defence Therapeutics Inc.
DTCFF
$0.6447
-$0.3517-35.30%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -575.00K | -444.90K | -985.30K | -984.80K | -6.12M |
| Total Depreciation and Amortization | 12.70K | 13.00K | 35.50K | 16.70K | 0.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 189.30K | 130.70K | 108.90K | 70.40K | 6.12M |
| Change in Net Operating Assets | -104.50K | 365.40K | 452.00K | 199.80K | 0.00 |
| Cash from Operations | -477.50K | 64.10K | -388.90K | -697.90K | 0.00 |
| Capital Expenditure | -- | -- | 12.40K | -158.50K | 0.00 |
| Sale of Property, Plant, and Equipment | 13.30K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 13.30K | -- | 12.40K | -158.50K | 0.00 |
| Total Debt Issued | 0.00 | 15.00K | 50.00K | -- | -- |
| Total Debt Repaid | -129.50K | -27.80K | -7.80K | -7.80K | 0.00 |
| Issuance of Common Stock | 800.00K | -- | 15.00K | 1.45M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -21.40K | -- | 0.00 | -124.60K | -- |
| Cash from Financing | 463.70K | -9.40K | 41.80K | 977.70K | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -500.00 | 54.70K | -334.70K | 121.30K | 0.00 |